Vincerx Pharma Inc (VINC)
0.8771
-0.05
(-5.69%)
USD |
NASDAQ |
May 03, 16:00
0.877
0.00 (0.00%)
After-Hours: 20:00
Vincerx Pharma Total Assets (Quarterly): 18.22M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 18.22M |
| September 30, 2023 | 26.28M |
| June 30, 2023 | 35.28M |
| March 31, 2023 | 47.45M |
| December 31, 2022 | 59.29M |
| September 30, 2022 | 72.38M |
| June 30, 2022 | 87.74M |
| Date | Value |
|---|---|
| March 31, 2022 | 103.88M |
| December 31, 2021 | 117.68M |
| September 30, 2021 | 129.42M |
| June 30, 2021 | 91.14M |
| March 31, 2021 | 58.00M |
| December 31, 2020 | 63.19M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
18.22M
Minimum
Dec 2023
129.42M
Maximum
Sep 2021
69.99M
Average
63.19M
Median
Dec 2020
Total Assets (Quarterly) Benchmarks
| Trxade Health Inc | 12.53M |
| MyMD Pharmaceuticals Inc | 17.86M |
| Acrivon Therapeutics Inc | 138.26M |
| Ligand Pharmaceuticals Inc | 787.22M |
| Regulus Therapeutics Inc | 30.75M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.995M |
| Shareholders Equity (Quarterly) | 11.22M |